| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.928 | 0 | 0.928 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.439 0.001 DBMET02978 | ||
| 0.276 | 0.067 | 0.276 | Cardiotonic | |||
| 0.167 | 0.022 | 0.173 | Papain-like protease (SARS coronavirus) inhibitor | 0.173 0.019 DBMET02978 | DBMET02978 | |
| 0.218 | 0.155 | 0.227 | Ca(v)3.3 blocker | 0.227 0.139 DBMET02978 | DBMET02978 | |
| 0.108 | 0.047 | 0.108 | mTOR complex 1 inhibitor | 0.104 0.054 DBMET02978 | ||
| 0.102 | 0.047 | 0.102 | Ca(v)2.2 blocker | |||
| 0.085 | 0.036 | 0.085 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.063 DBMET02978 | ||
| 0.037 | 0.016 | 0.04 | Potassium channel subfamily K member 3 blocker | 0.04 0.014 DBMET02978 | DBMET02978 | |
| 0.196 | 0.176 | 0.257 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.257 0.057 DBMET02978 | DBMET02978 | |
| 0.035 | 0.015 | 0.035 | Complement C5a chemotactic receptor antagonist | |||
| 0.075 | 0.057 | 0.075 | CC chemokine receptor antagonist | 0.074 0.058 DBMET02978 | ||
| 0.225 | 0.208 | 0.225 | Analgesic | |||
| 0.051 | 0.035 | 0.051 | CC chemokine 5 receptor antagonist | |||
| 0.087 | 0.078 | 0.091 | Chemokine receptor antagonist | 0.091 0.073 DBMET02978 | DBMET02978 | |
| 0.024 | 0.015 | 0.024 | Retinoid X gamma receptor agonist | |||
| 0.073 | 0.068 | 0.073 | Viral attachment inhibitor | |||
| 0.065 | 0.066 | 0.071 | Phosphodiesterase VIII inhibitor | 0.071 0.051 DBMET02978 | DBMET02978 | |
| 0.135 | 0.139 | 0.142 | Cyclin-dependent kinase 3 inhibitor | 0.142 0.116 DBMET02978 | DBMET02978 | |
| 0.099 | 0.106 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.098 DBMET02978 | DBMET02978 | |
| 0.123 | 0.135 | 0.153 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.153 0.068 DBMET02978 | DBMET02978 | |
| 0.063 | 0.114 | 0.126 | Protein kinase C mu inhibitor | 0.126 0.038 DBMET02978 | DBMET02978 | |
| 0.012 | 0.071 | 0.025 | Motilin receptor agonist | 0.025 0.014 DBMET02978 | DBMET02978 | |
| 0.034 | 0.096 | 0.063 | CC chemokine 2 receptor antagonist | 0.063 0.03 DBMET02978 | DBMET02978 | |
| 0.125 | 0.19 | 0.248 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.248 0.044 DBMET02978 | DBMET02978 | |
| 0.238 | 0.308 | 0.312 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.312 0.197 DBMET02978 | DBMET02978 | |
| 0.117 | 0.207 | 0.166 | Death-associated protein kinase 2 inhibitor | 0.166 0.075 DBMET02978 | DBMET02978 | |
| 0.188 | 0.294 | 0.293 | MAP kinase kinase 6 inhibitor | 0.293 0.142 DBMET02978 | DBMET02978 | |
| 0.096 | 0.207 | 0.157 | Potassium channel blocker | 0.157 0.129 DBMET02978 | DBMET02978 | |
| 0.038 | 0.153 | 0.068 | Bcl2 antagonist | 0.068 0.045 DBMET02978 | DBMET02978 | |
| 0.036 | 0.159 | 0.078 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.078 0.075 DBMET02978 | DBMET02978 | |
| 0.042 | 0.165 | 0.126 | Platelet activating factor alpha antagonist | 0.126 0.041 DBMET02978 | DBMET02978 | |
| 0.033 | 0.179 | 0.091 | Rho-associated kinase II inhibitor | 0.091 0.037 DBMET02978 | DBMET02978 | |
| 0.033 | 0.191 | 0.071 | MAP kinase kinase 10 inhibitor | 0.071 0.039 DBMET02978 | DBMET02978 | |
| 0.091 | 0.257 | 0.168 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.168 0.121 DBMET02978 | DBMET02978 | |
| 0.054 | 0.308 | 0.162 | Heat shock protein 90 antagonist | 0.162 0.062 DBMET02978 | DBMET02978 | |
| 0.052 | 0.329 | 0.143 | Heat shock protein 90 alpha antagonist | 0.143 0.094 DBMET02978 | DBMET02978 | |
| 0.13 | 0.416 | 0.376 | MAP kinase 1 inhibitor | 0.376 0.12 DBMET02978 | DBMET02978 | |
| 0.028 | 0.316 | 0.124 | EphA2 antagonist | 0.124 0.051 DBMET02978 | DBMET02978 | |
| 0.027 | 0.315 | 0.089 | MAP kinase 8 inhibitor | 0.089 0.074 DBMET02978 | DBMET02978 | |
| 0.059 | 0.396 | 0.126 | MAP kinase 3 inhibitor | 0.126 0.118 DBMET02978 | DBMET02978 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |